Becker's Healthcare September 9, 2019
Andrea Park

Significant reforms are necessary in researchers’ relationships with drug regulators and physicians to ensure their discoveries are accessible to those who need them most, according to Janet Woodcock, MD, director of the FDA’s Center for Drug Evaluation and Research.

As is, the current healthcare ecosystem discourages collaboration, preventing many potentially life-saving treatments from ever making it from the lab to the clinic, Dr. Woodcock said at the Breakthroughs in Medicine conference on Sept. 6, the Los Angeles Times reports. When drugs do begin the process of commercialization, they are shrouded in a level of secrecy that makes clinical trials excessively costly and fragmented.

“The goal isn’t just improving knowledge. The goal isn’t FDA approval. The goal is to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: EMR / EHR, FDA, Govt Agencies, Insurance, Pharma, Physician, Provider, Regulations, Technology
FDA Approves Winrevair, Merck’s Novel Treatment for Pulmonary Arterial Hypertension
FDA approves Merck drug for rare lung disorder
Neuronetics wins FDA clearance for device to treat adolescents with depression
FDA Approves Roche’s Cobas Malaria Test, Designed to Screen for Malaria in Potential Blood Donors
Merck Drug for Heart and Lung Disorder Wins a First-in-Class FDA Approval

Share This Article